Debasis Mondal - Concepedia

Author

Debasis Mondal

Also Known As

D Mondal, D. Mondal, DEBASIS MONDAL, Debasis Mondal, Dr Aniruddha Mondal, Mondal D., Shannon Jiang Rao, Tse-Dinh, Yuk-Ching

144

Publications

4.1K

Citations

H-Index

117

Concepts

All Affiliations

Tulane University Uppsala University University Medical Center New Orleans Louisiana State University Health Sciences Center New Orleans University Hospital and Clinics

About

Debasis Mondal is an author at Tulane University specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	36	2K
2	Health Sciences	4	4	199
3	Natural Sciences	4	4	294
4	Public Health	1	1	42
5	Allergy	1	1	30

Debasis Mondal

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Neoplastic Reprogramming of Patient-Derived Adipose Stem Cells by Prostate Cancer Cell-Associated Exosomes Zakaria Y. Abd Elmageed, Yijun Yang, Raju Thomas, Stem Cells	2013	298
High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer Amrita Datta, Hogyoung Kim, Lauren McGee, Scientific Reports	2018	280
Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1α (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway–Dependent NF-κB Activation Promil Kukreja, Asim B. Abdel‐Mageed, Debasis Mondal, Cancer Research Cxcr4 Mrna ExpressionImmunologyImmune RegulationCxcr4 ExpressionInflammation	2005	207
Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells Amrita Datta, Hogyoung Kim, Madhu Lal, Cancer Letters Hnrnp H1MedicineExosome BiogenesisManumycin AAnti-cancer Agent	2017	207
Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species Padma Sandeep Koka, Debasis Mondal, Michelle Schultz, Experimental Biology and Medicine Androgen ReceptorReactive Oxygen SpeciesChemoprevention StrategyOncogenic AgentMedicine	2010	148
Anticancer and chemosensitizing abilities of cycloviolacin O2 from <i>Viola odorata</i> and psyle cyclotides from <i>Psychotria leptothyrsa</i> Samantha L. Gerlach, Ramesh Rathinakumar, Geetika Chakravarty, Biopolymers PharmacotherapyCancer BiologyExperimental PharmacologyPharmaceutical ChemistryTumor Biology	2010	115
HAART Drugs Induce Oxidative Stress in Human Endothelial Cells and Increase Endothelial Recruitment of Mononuclear Cells: Exacerbation by Inflammatory Cytokines and Amelioration by Antioxidants Debasis Mondal, Leena Pradhan, Mussa Ali, Cardiovascular Toxicology InflammationInflammatory CytokinesMedicineLipid PeroxidationImmunology	2004	108
Doxorubicin resistance in breast cancer is driven by light at night‐induced disruption of the circadian melatonin signal Shulin Xiang, Robert T. Dauchy, Adam Hauch, Journal of Pineal Research	2015	97
Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer Geetika Chakravarty, Krzysztof Moroz, Nick Makridakis, Experimental Biology and Medicine	2011	86
MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells Mark Eilers, Upal Roy, Debasis Mondal Experimental Biology and Medicine ImmunologyAntiviral DrugDrug ResistanceMolecular PharmacologyTransporters-mediated Efflux	2008	79

Page 1